🟢 NeoGenomics is trading 4.13% up in pre-market ahead of October 28 Q3 results

NeoGenomics is trading at $17.38, up 4.13%, as investors position ahead of its October 28 Q3 results.

• The company previously announced preliminary Q3 revenue of approximately $209 million and NGS revenue growth of approximately 28%.
• NeoGenomics has not reported earnings; its investor relations release says results are due after the market close on October 28.
• Major U.S. indices are modestly higher, with no confirmed company announcement on October 27.